{{DISPLAYTITLE:''N'',''alpha''-Diethylphenylethylamine}}
{{Drugbox
| drug_name = ''N'',α-Diethylphenylethylamine
| IUPAC_name = ''N''-Ethyl-1-phenylbutan-2-amine
| image = ethylphenylbutanamine_structure.png
| width = 240

<!--Clinical data-->
| tradename =  
| legal_NZ = Class C
| legal_CA = Schedule I
| legal_UK = Class A
| routes_of_administration =

<!--Pharmacokinetic data-->
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number = 119486-07-6
| CAS_supplemental = <br />29805-52-5 ([[Hydrochloride|HCl]])
| PubChem = 14833603
| ChemSpiderID = 27101303
| synonyms = ''N'',α-DEPEA

<!--Chemical data-->
| C=12 | H=19 | N=1
| molecular_weight = 177.285 g/mol
| smiles = C(C)NC(CC1=CC=CC=C1)CC
| StdInChI = 1S/C12H19N/c1-3-12(13-4-2)10-11-8-6-5-7-9-11/h5-9,12-13H,3-4,10H2,1-2H3
| StdInChIKey = KHWYSUBVXWWBRB-UHFFFAOYSA-N
}}

'''''N'',α-Diethylphenylethylamine''' ('''''N'',α-DEPEA''', '''2-ethylamino-1-phenylbutane''', '''EAPB''') is a close chemical analog of [[methamphetamine]] which has been sold as a [[designer drug]].<ref>{{cite journal | url=http://www.sciencedirect.com/science/article/pii/S0731708515300790 | title=Determination of designer doping agent – 2-ethylamino-1-phenylbutane – in dietary supplements and excretion study following single oral supplement dose |author1=Marzena Wójtowicz |author2=Anna Jarek |author3=Katarzyna Chajewska |author4=Ewa Turek-Lepa |author5=Dorota Kwiatkowska | journal=Journal of Pharmaceutical and Biomedical Analysis | date=November 2015 | volume=115 | pages=523–533 | doi=10.1016/j.jpba.2015.07.025 | pmid=26311473}}</ref><ref>{{cite journal | url=http://jat.oxfordjournals.org/content/38/2/106 | title=Designer phenethylamines routinely found in human urine: 2-ethylamino-1-phenylbutane and 2-amino-1-phenylbutane. |author1=Victor Uralets |author2=Mike App |author3=Sumandeep Rana |author4=Stewart Morgan |author5=Wayne Ross | journal=Journal of Analytical Toxicology | date=January 2014 | volume=38 | issue=2 | pages=106–109 | doi=10.1093/jat/bkt121 | pmid=24451085}}</ref><ref>{{cite web | url=https://www.caymanchem.com/app/template/Product.vm/catalog/9001863 | title=2-Ethylamino-1-phenylbutane | publisher=Cayman Chemical | accessdate=4 November 2015}}</ref> It was originally patented by Knoll Pharma as one of several analogs for pharmaceutical applications. In animals models these analogs showed properties of cognitive enhancement and increased pain tolerance.<ref name="Korea2">{{cite journal | doi = 10.1007/s11419-013-0205-6| title = Identification and quantitation of N,α-diethylphenethylamine in preworkout supplements sold via the Internet| journal = Forensic Toxicology| volume = 32| pages = 148| year = 2013| last1 = Lee| first1 = Jaesin| last2 = Venhuis| first2 = Bastiaan J.| last3 = Heo| first3 = Sewoong| last4 = Choi| first4 = Hyeyoung| last5 = Seol| first5 = Ilung| last6 = Kim| first6 = Eunmi}}</ref> Nevertheless, this class of compounds was never developed into a medicine.
{{nowrap|''N'',α-DEPEA}} has not been studied in humans, but experts such as Pieter Cohen of [[Harvard Medical School]] expect it to be less potent than methamphetamine, but greater than [[ephedrine]].<ref name="Nutraingredients">{{cite web | url = http://www.nutraingredients-usa.com/Regulation/Craze-manufacturer-disputes-NSF-s-discovery-of-drug-tainting | title = Craze manufacturer disputes NSF's discovery of drug tainting | publisher = Nutraingredients | date = October 17, 2013}}</ref>

==Adulterant in nutritional supplements==
In January 2013, the Korean authorities reported seizing a large quantity of the pure material, predicting it would soon be found on the market.<ref name="Korea1">{{cite web | url = https://link.springer.com/article/10.1007%2Fs11419-012-0158-1| title = Identification of N-ethyl-α-ethylphenethylamine in crystalline powder seized for suspected drug trafficking: A research chemical or a new designer drug? | publisher = Springer | date = January 2013}}</ref>  Later in 2013, it was found as an adulterant in biologically significant amounts in the pre-workout supplements Craze (marketed by Driven Sports, Inc.) and  Detonate (marketed by Gaspari Nutrition).<ref name="Korea2"/><ref>{{Cite news | url = https://www.usatoday.com/story/news/nation/2013/10/14/tests-of-supplements-craze-and-detonate-find-methamphetamine-like-compound/2968041/ | publisher = USA Today | date = October 25, 2013 | title = Popular sports supplements contain meth-like compound}}</ref> It was falsely claimed to be ''[[Dendrobium]]'' extract.<ref name="Nutraingredients"/><ref name="Cohen">{{cite journal | doi = 10.1002/dta.1578| pmid = 24124092| title = A methamphetamine analog (N,α-diethyl-phenylethylamine) identified in a mainstream dietary supplement| journal = Drug Testing and Analysis| volume = 6| issue = 7–8| pages = 805| year = 2014| last1 = Cohen| first1 = Pieter A.| last2 = Travis| first2 = John C.| last3 = Venhuis| first3 = Bastiaan J.}}</ref><ref>[http://www.nzherald.co.nz/nz/news/article.cfm?c_id=1&objectid=11156658 Warning issued over CRAZE sports supplement. New Zealand Herald, 13 November 2013]</ref>

==See also==
* [[Buphedrone]]
* [[Butylone]]
* [[1,3-Benzodioxolyl-N-ethylbutanamine|EBDB]]
* [[Etilamfetamine]]
* [[Eutylone]]
* [[N-Ethylbuphedrone|''N''-Ethylbuphedrone]]
* [[Phenylisobutylamine]]

==References==
{{Reflist}}

{{Stimulants}}
{{Nootropics}}
{{Phenethylamines}}

{{DEFAULTSORT:Diethylphenylethylamine, N,alpha-}}
[[Category:Designer drugs]]
[[Category:Norepinephrine-dopamine releasing agents]]
[[Category:Phenethylamines]]
[[Category:Substituted amphetamines]]